NVCRVSSLS• 6 Months (Normalized)
NVCR vs SLS (NovoCure Limited vs SELLAS Life Sciences Group Inc.)
Showing Closing Date Range from Mar, 20 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
NVCR Performance $16.22
+37.34%
NovoCure Limited
Normalized Baseline0.00%
SLS Performance $11.66
+144.96%
SELLAS Life Sciences Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin SLS LEADS
-107.62%
SLS outperforming by 107.62%
NVCRSLS
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
NVCR SLS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | NVCR Price | NVCR Gain (%) | SLS Price | SLS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $16.22 | +37.34% | $11.66 | +144.96% | -107.62% |
| Sep 15, 2026 | $16.15 | +36.75% | $11.29 | +137.18% | -100.43% |
| Sep 14, 2026 | $16.22 | +37.34% | $11.73 | +146.43% | -109.09% |
| Sep 11, 2026 | $15.51 | +31.33% | $11.55 | +142.65% | -111.32% |
| Sep 10, 2026 | $15.35 | +29.97% | $13.49 | +183.40% | -153.43% |
| Sep 09, 2026 | $15.63 | +32.35% | $13.95 | +193.07% | -160.72% |
| Sep 08, 2026 | $16.85 | +42.68% | $13.96 | +193.28% | -150.60% |
| Sep 04, 2026 | $17.94 | +51.91% | $13.86 | +191.18% | -139.27% |
| Sep 03, 2026 | $17.64 | +49.36% | $13.70 | +187.82% | -138.46% |
| Sep 02, 2026 | $17.83 | +50.97% | $14.16 | +197.48% | -146.51% |
| Sep 01, 2026 | $17.38 | +47.16% | $13.22 | +177.73% | -130.57% |
| Aug 31, 2026 | $17.65 | +49.45% | $13.34 | +180.25% | -130.80% |
| Aug 28, 2026 | $17.82 | +50.89% | $13.21 | +177.52% | -126.63% |
| Aug 27, 2026 | $17.99 | +52.33% | $15.21 | +219.54% | -167.21% |
| Aug 26, 2026 | $17.89 | +51.48% | $13.73 | +188.45% | -136.97% |
Page 1 of 9